This inventor holds 1 USPTO granted patent. Top assignees: Industry-University Cooperation Foundation Hanyang University, Korea Institute of Science and Technology. Active years: 2019.
Company Filing History:
1 out of 1,229 
1 out of 2,248 
Years Active: 2019
Title: In Jae Shun: Innovator in Anticancer Research
Introduction
In Jae Shun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. His work is characterized by a focus on innovative solutions to combat tumor diseases.
Latest Patents
In Jae Shun holds a patent for a novel compound titled "Substituted pyrimidine-4-carboxylic acids having anticancer activity." This invention relates to a pyrimidine-4-carboxylic acid derivative that exhibits anticancer activity. The compound is useful as a drug for treating and preventing tumor diseases, showcasing its potential impact on cancer treatment.
Career Highlights
Throughout his career, In Jae Shun has been associated with prominent institutions such as the Korea Institute of Science and Technology and the Industry-University Cooperation Foundation at Hanyang University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
In Jae Shun has collaborated with notable colleagues, including Tae Bo Sim and Woo Young Hur. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research.
Conclusion
In Jae Shun's innovative work in the field of anticancer research exemplifies the importance of scientific advancements in medicine. His contributions through patents and collaborations highlight his commitment to improving health outcomes for patients.